Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway.
Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls.
Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration.
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.
Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells.
